Philadelphia chromosome–like acute lymphoblastic leukemia
Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL), also referred to as
BCR-ABL1–like ALL, is a high-risk subset with a gene expression profile that shares …
BCR-ABL1–like ALL, is a high-risk subset with a gene expression profile that shares …
Biologic and therapeutic implications of genomic alterations in acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is the most successful paradigm of how risk-adapted
therapy and detailed understanding of the genetic alterations driving leukemogenesis and …
therapy and detailed understanding of the genetic alterations driving leukemogenesis and …
Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL
Genomic classification has improved risk assignment of pediatric, but not adult B-lineage
acute lymphoblastic leukemia (B-ALL). The international UKALLXII/ECOG-ACRIN E2993 (# …
acute lymphoblastic leukemia (B-ALL). The international UKALLXII/ECOG-ACRIN E2993 (# …
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group
KG Roberts, SC Reshmi, RC Harvey… - Blood, The Journal …, 2018 - ashpublications.org
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL; BCR-ABL1–like
ALL) in children with National Cancer Institute (NCI) intermediate-or high-risk (HR) ALL is …
ALL) in children with National Cancer Institute (NCI) intermediate-or high-risk (HR) ALL is …
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
AV Moorman, E Barretta, ER Butler, EJ Ward… - Leukemia, 2022 - nature.com
Chromosomal abnormalities are established prognostic markers in adult ALL. We assessed
the prognostic impact of established chromosomal abnormalities and key copy number …
the prognostic impact of established chromosomal abnormalities and key copy number …
Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia
RC Harvey, SK Tasian - Blood advances, 2020 - ashpublications.org
Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (Ph-like ALL) accounts
for 15% to 30% of B-cell acute lymphoblastic leukemia in older children, adolescents, and …
for 15% to 30% of B-cell acute lymphoblastic leukemia in older children, adolescents, and …
Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL
KG Roberts, YL Yang, D Payne-Turner, W Lin… - Blood …, 2017 - ashpublications.org
New therapies for Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like
ALL) patients are urgently needed. The genetic landscape of Ph-like ALL is characterized by …
ALL) patients are urgently needed. The genetic landscape of Ph-like ALL is characterized by …
Philadelphia chromosome–like acute lymphoblastic leukemia
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is a recently
described B-cell precursor ALL with a gene expression profile and a high frequency of IKZF1 …
described B-cell precursor ALL with a gene expression profile and a high frequency of IKZF1 …
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease …
Early recognition of Philadelphia-like (Ph-like) acute lymphoblastic leukemia (ALL) cases
could impact on the management and outcome of this subset of B-lineage ALL. In order to …
could impact on the management and outcome of this subset of B-lineage ALL. In order to …
Recent advances in managing acute lymphoblastic leukemia
DJ DeAngelo, E Jabbour, A Advani - American Society of Clinical …, 2020 - ascopubs.org
Acute lymphoblastic leukemia (ALL) is characterized by chromosomal translocations and
somatic mutations that lead to leukemogenesis. The incorporation of pediatric-type regimens …
somatic mutations that lead to leukemogenesis. The incorporation of pediatric-type regimens …